Shengli Dong

789 total citations
40 papers, 580 citations indexed

About

Shengli Dong is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shengli Dong has authored 40 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shengli Dong's work include Cancer Cells and Metastasis (6 papers), Advanced Breast Cancer Therapies (4 papers) and MicroRNA in disease regulation (3 papers). Shengli Dong is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Advanced Breast Cancer Therapies (4 papers) and MicroRNA in disease regulation (3 papers). Shengli Dong collaborates with scholars based in China, United States and India. Shengli Dong's co-authors include Suresh K. Alahari, J. Michael Mathis, Somesh Baranwal, Gaopeng Li, Mazvita Maziveyi, Zizhuo Zhao, Cristina Ivan, Zhengang Sun, Xi Ai and Jian Guan and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Shengli Dong

37 papers receiving 572 citations

Peers

Shengli Dong
Comparison fields: 5 of 88
  • Molecular Biology 361
  • Cancer Research 227
  • Oncology 130
  • Hepatology 65
  • Surgery 59
Replace Devis Pascut with:
Devis Pascut Italy
Leilei Niu China
Zhenzhen Xu China
Leping Yang China
Hulin Chang China
Ruixiu Zhang China
Eunsun Jung South Korea
Michele Baglioni Italy
Karl Quint Germany
Devis Pascut Italy View profile →
Citations per field, relative to Shengli Dong
Shengli Dong · 1×
Citations per year, relative to Shengli Dong
Shengli Dong · 1×

Countries citing papers authored by Shengli Dong

Since Specialization
Citations

This map shows the geographic impact of Shengli Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengli Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengli Dong more than expected).

Fields of papers citing papers by Shengli Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengli Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengli Dong. The network helps show where Shengli Dong may publish in the future.

Co-authorship network of co-authors of Shengli Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Shengli Dong. A scholar is included among the top collaborators of Shengli Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengli Dong. Shengli Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 4
2 2
3 3
4 1
5 1
6 6
7 3
8 0
9 31
10 8
11 53
12 8
13 20
14 90
15 10
16 10
17 8
18 45
19 49
20 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026